Anti-Inflammatory Peptide Shows Potential to Prevent Diabetes-Related Vision Loss
Tests used lab-grown retinal cells and mini-retinas, not patients, and Brazilian researcher Cristiane Gil says animal and human studies must come first.
4 Articles
4 Articles
Anti-inflammatory peptide protects retinal neurons in experimental diabetic retinopathy models
Tests on lab-grown “mini-retinas” show that the anti-inflammatory peptide Ac2-26 prevents the death of neurons exposed to high levels of glucose and inflammation – conditions typical of diabetic retinopathy.
Anti-inflammatory peptide shows potential to prevent diabetes-related vision loss
According to a study published in October in the journal Biomedicine & Pharmacotherapy, a molecule naturally produced by the human body may help protect vision against damage caused by high blood sugar. This finding paves the way for new strategies to prevent diabetic retinopathy. This complication affects more than 22% of people with diabetes worldwide. It occurs when high blood sugar levels cause inflammation and damage neurons and blood vesse…
A recent study found that a molecule naturally produced by the body could help protect the eyesight from the damage caused by the high blood sugar, which could pave the way for the very strategies of the brain.
Tests in miniretins show that anti-inflammatory peptide prevents the death of neurons caused by excess glucose. Read on Power360.
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium







